Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04781192 |
| Title | The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Kansas Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Kansas Cancer Center - Overland Park | Recruiting | Overland Park | Kansas | 66210 | United States | Details |
| The University of Kansas Medical Center | Recruiting | Westwood | Kansas | 66205 | United States | Details |
| University of Kansas Cancer Center - North | Recruiting | Kansas City | Missouri | 64154 | United States | Details |
| University of Kansas Cancer Center - Lee's Summit | Recruiting | Lee's Summit | Missouri | 64064 | United States | Details |
| The University of Kansas Medical Center | Recruiting | North Kansas City | Missouri | 64116 | United States | Details |